| Carla Ellis, | |
|
117 W Medical Ct, Marion, NC 28752-5590 | |
| (828) 659-3966 | |
| (828) 659-6304 |
| Full Name | Carla Ellis |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 117 W Medical Ct, Marion, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366781288 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 52579 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carla Ellis, 515 Clanton Rd, Charlotte, NC 28217-1309 Ph: (704) 332-9001 | Carla Ellis, 117 W Medical Ct, Marion, NC 28752-5590 Ph: (828) 659-3966 |
News Archive
John Schlitt, director of the Pew Home Visiting Campaign, a project of the Pew Center on the States, issued the following statement today, commenting on maternal and infant home visiting provisions included in Health Care Reform legislation as passed by the 111th United States Congress. The bill establishes a $1.5 billion federal grant program for evidence-based state home visitation for new and expectant families.
Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based Medicine Project. The project is a national consortium of cutting-edge hospitals and academic centers working to improve treatment and survival for patients with a kind of malignant brain tumor called a glioma.
Cell Therapeutics, Inc. today announced that the Company has been granted market access by the Italian Medicines Agency for the medicinal product PIXUVRI (pixantrone) as a monotherapy for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma (patients with aggressive B-cell NHL who failed 2 or 3 prior lines of therapy).
Sepsis, the body's life-threatening response to infection affecting about 1.7 million adults in the United States each year, can lead to multisystem organ failure with a high mortality rate.
The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.
› Verified 5 days ago
Cindy Dawn Martin, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 W Medical Ct, Marion, NC 28752 Phone: 828-659-3966 Fax: 828-659-6304 | |
Judy Watring, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 W Medical Ct, Marion, NC 28752 Phone: 828-659-3966 Fax: 828-659-6304 | |
Victoria Ann Goforth, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 W Medical Ct, Marion, NC 28752 Phone: 828-659-3966 Fax: 828-659-6304 | |
Taylor Lynn Maltba, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3100 Nc 226 S, Marion, NC 28752 Phone: 828-655-3231 Fax: 828-559-0881 | |
Christopher Williams, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 217 Kathy St, Marion, NC 28752 Phone: 828-317-1353 | |
Terry Arrowood, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 117 W Medical Ct, Marion, NC 28752 Phone: 828-659-3966 Fax: 828-659-6304 |